tiprankstipranks
XTL Biopharmaceuticals Announces Upcoming Shareholder Meeting
Company Announcements

XTL Biopharmaceuticals Announces Upcoming Shareholder Meeting

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update.

Don't Miss Our Christmas Offers:

XTL Biopharmaceuticals Ltd. is set to hold its Annual and Extraordinary General Meeting on July 22, 2024, to discuss crucial corporate matters including the previous year’s auditor’s report, re-appointing auditors, re-electing Board members, and approving the acquisition of The Social Proxy Ltd. Shareholders as of June 24, 2024, will be able to vote in person or by proxy, with the Board recommending a vote ‘FOR’ on all agenda items. Key decisions include the issuance of shares and payment for the acquisition, alongside electing new directors contingent upon the deal’s completion.

For further insights into XTLB stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskXTL Biopharmaceuticals Adjusts Shares, Eyes Expansion
TipRanks Auto-Generated NewsdeskXTL Biopharmaceuticals Resolves Dispute with Social Proxy
TipRanks Auto-Generated NewsdeskXTL Biopharmaceuticals Faces Financial Dispute After Acquisition
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App